tiprankstipranks
Trending News
More News >
KalVista Pharmaceuticals (KALV)
NASDAQ:KALV
US Market
Advertisement

KalVista Pharmaceuticals (KALV) Financial Statements

Compare
511 Followers

KalVista Pharmaceuticals Financial Overview

KalVista Pharmaceuticals's market cap is currently $788.77M. The company's EPS TTM is $-0.99; its P/E ratio is ―; KalVista Pharmaceuticals is scheduled to report earnings on July 10, 2025, and the estimated EPS forecast is $-0.95. See an overview of income statement, balance sheet, and cash flow financials.
Jun 25Jun 24Jun 23Jun 22Jun 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00$ 0.00$ 12.69M
Gross Profit$ 0.00$ -86.17M$ -802.00K$ -743.00K$ 12.04M
Operating Income$ -188.00M$ -140.44M$ -110.87M$ -96.61M$ -57.92M
EBITDA$ -173.33M$ -134.28M$ -92.11M$ -81.60M$ -45.59M
Net Income$ -183.44M$ -126.64M$ -74.85M$ -68.51M$ -44.49M
Balance Sheet
Cash & Short-Term Investments$ 187.65M$ 210.40M$ 149.38M$ 166.20M$ 248.93M
Total Assets$ 250.77M$ 235.40M$ 183.20M$ 203.88M$ 272.01M
Total Debt$ 6.31M$ 7.32M$ 8.23M$ 8.19M$ 5.91M
Net Debt$ -92.34M$ -24.47M$ -48.01M$ -22.54M$ -44.68M
Total Liabilities$ 155.38M$ 28.82M$ 22.18M$ 18.79M$ 14.82M
Stockholders' Equity$ 95.39M$ 206.58M$ 161.03M$ 185.09M$ 257.19M
Cash Flow
Free Cash Flow$ -152.91M$ -89.67M$ -76.46M$ -79.06M$ -30.25M
Operating Cash Flow$ -152.91M$ -89.23M$ -75.26M$ -78.13M$ -30.17M
Investing Cash Flow$ 91.02M$ -84.72M$ 41.41M$ 57.86M$ -147.65M
Financing Cash Flow$ 159.73M$ 150.71M$ 58.12M$ 1.58M$ 212.12M
Currency in USD

KalVista Pharmaceuticals Earnings and Revenue History

KalVista Pharmaceuticals Debt to Assets

KalVista Pharmaceuticals Cash Flow

KalVista Pharmaceuticals Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis